Author

G. Turkoz

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. Harisankar· 1 shared B. C. Mandaci· 1 shared B. Dingiloglu· 1 shared C. Eren· 1 shared C. Pamukcu· 1 shared E. Celik· 1 shared E. Z. Ergun· 1 shared G. Dinler Doganay· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Harisankar

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Identification of GTF2IRD1 as a novel transcription factor essential for acute myeloid leukemia

Y. Heshmati, G. Turkoz, J. Zawacka, M. Dimitriou, A. Harisankar, J. Bostrom, H. Cai, N. Kadri, M. Altun, H. Qian, J. Walfridsson

This study identifies GTF2IRD1 as a novel transcription factor essential for AML cell survival and disease progression, with potential therapeutic implications.

bioRxiv · Aug 9, 2022 · PreprintCancer Biology

Lentiviral vector-based SARS-CoV-2 pseudovirus enables analysis of neutralizing activity in COVID-19 convalescent plasma

C. Pamukcu, E. Celik, E. Z. Ergun, Z. S. Karahan, G. Turkoz, M. Aras, C. Eren, U. Sili, H. Bilginer, I. Suder, B. C. Mandaci, B. Dingiloglu, O. Tatli, G. Dinler Doganay, S. Baris, , T. Sutlu

This study develops a lentiviral pseudovirus system to measure neutralizing activity in COVID-19 convalescent plasma, showing that neutralizing activity depends on antibody quality rather than quantity.

bioRxiv · Dec 28, 2020 · PreprintImmunology